Lisa Kamen
Corporate Officer/Principal at BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Profile
Lisa Kamen is a professional who currently works as a Senior Director-Clinical Operations at Biohaven Pharmaceutical Holding Co. Ltd.
She has also worked as a Director-Clinical Operations at Spinifex Pharmaceuticals Pty Ltd.
and as a Principal at Bristol Myers Squibb Co. Kamen has an undergraduate degree from the University of Rhode Island and a graduate degree from Quinnipiac University.
Currently, Kamen is working as a Senior Director-Clinical Operations at Biohaven Pharmaceutical Holding Co. Ltd.
Lisa Kamen active positions
Companies | Position | Start |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | - |
Former positions of Lisa Kamen
Companies | Position | End |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Spinifex Pharmaceuticals Pty Ltd.
Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Spinifex Pharmaceuticals Pty Ltd. discovers and develops new drugs for the treatment and management of pain. The firm conducts medicinal chemistry and drug discovery activities, preclinical and early-phase clinical studies before seeking a partnership with pharmaceutical company to complete clinical development, file for regulatory approval, and carry out marketing activities. The company was founded in June 2005 and is headquartered in Preston, Australia. | Chief Tech/Sci/R&D Officer | - |
Training of Lisa Kamen
University of Rhode Island | Undergraduate Degree |
Quinnipiac University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private companies | 2 |
---|---|
Spinifex Pharmaceuticals Pty Ltd.
Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Spinifex Pharmaceuticals Pty Ltd. discovers and develops new drugs for the treatment and management of pain. The firm conducts medicinal chemistry and drug discovery activities, preclinical and early-phase clinical studies before seeking a partnership with pharmaceutical company to complete clinical development, file for regulatory approval, and carry out marketing activities. The company was founded in June 2005 and is headquartered in Preston, Australia. | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Stock Market
- Insiders
- Lisa Kamen